Edition:
International

Miyoung Kim

U.S. health body questions AstraZeneca's COVID-19 vaccine trial data

Mar 23 2021

SINGAPORE AstraZeneca may have released outdated information on its latest COVID-19 vaccine trial, giving an "incomplete" picture of its efficacy, a leading U.S. health agency said on Tuesday, casting doubt on the shot's potential U.S. rollout and plunging its developers, once again, into controversy. | Video

REUTERS NEXT-Don't expect a conclusion from WHO's China visit, says expert

Jan 11 2021

SINGAPORE, Jan 11 Expectations should be "very low" that a World Health Organization team of experts tasked with investigating the origins of the COVID-19 pandemic will reach a conclusion from their trip to China this month, a health expert affiliated with the WHO said.

Sinovac's COVID-19 vaccine induces quick immune response: study

Nov 18 2020

SINGAPORE/BEIJING Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday. | Video

Sinovac's COVID-19 vaccine induces quick immune response - study

Nov 17 2020

SINGAPORE/BEIJING Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.

Sinovac's COVID-19 vaccine induces quick immune response - study

Nov 17 2020

SINGAPORE/BEIJING, Nov 18 Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.

Samsung's Lee: tainted titan who built a global tech giant

Oct 25 2020

SEOUL In February 1993, five years after taking over from his father at South Korea's Samsung Group, 51-year-old Lee Kun-hee was frustrated that he wasn't making his mark. | Video

Samsung's Lee: tainted titan who built a global tech giant

Oct 25 2020

SEOUL In February 1993, five years after taking over from his father at South Korea's Samsung Group, 51-year-old Lee Kun-hee was frustrated that he wasn't making his mark.

CORRECTED-OBITUARY-Samsung's Lee: tainted titan who built a global tech giant

Oct 25 2020

SEOUL, Oct 25 In February 1993, five years after taking over from his father at South Korea's Samsung Group, 51-year-old Lee Kun-hee was frustrated that he wasn't making his mark.

In coronavirus vaccine race, China inoculates thousands before trials are completed

Sep 16 2020

SHANGHAI/SINGAPORE China is inoculating tens of thousands of its citizens with experimental coronavirus vaccines and attracting international interest in their development, despite expert concerns over the safety of drugs that have not completed standard testing.

A big obstacle: Where can CanSino test its vaccine abroad?

Jul 30 2020

BEIJING/SINGAPORE CanSino Biologics Inc , one of many companies worldwide trying to develop a coronavirus vaccine, needs to conduct late-stage trials overseas if it is to stay in the race, experts say, but it has yet to announce another country willing to help.

World News